Etiology


Classifications

Three classifications, same as Etiology


Pathophysiology

  • Severe glomerular injury leads to breaks in the glomerular basement membrane (GBM), allowing fibrin, inflammatory cells (macrophages), and parietal epithelial cells to proliferate in Bowman’s space, forming a characteristic crescent shape.
  • Release of inflammatory cytokines → damage to the membrane of Bowman space and passage of cells from the interstitium into Bowman space
  • This causes the formation of fibrin clots and proliferation of cells (e.g., macrophages, fibroblasts, neutrophils, epithelial cells) → crescent moon formation → compression of the glomerulus → renal dysfunction

Clinical features


Diagnostics

  • Serology: Crucial for classification.
    • Anti-GBM antibodies: Type I.
    • ANA, anti-dsDNA, low complement (C3/C4): Type II (if SLE).
    • c-ANCA (anti-PR3) / p-ANCA (anti-MPO): Type III.

Treatment

  • Urgent and aggressive immunosuppression is required to prevent irreversible renal failure.
  • General approach: High-dose corticosteroids (e.g., pulse methylprednisolone) PLUS another agent.
  • Specific therapy depends on type:
    • Type I (Anti-GBM): Corticosteroids + Cyclophosphamide + Plasmapheresis (to remove circulating anti-GBM antibodies).
    • Type II (Immune-Complex): Treat the underlying disease (e.g., SLE with steroids + cyclophosphamide or mycophenolate).
    • Type III (Pauci-Immune/ANCA): Corticosteroids + Cyclophosphamide or Rituximab. Plasmapheresis may be used in severe cases (e.g., pulmonary hemorrhage, dialysis requirement).

Mnemonic

激素环(II型、III型) 好怕 (Goodpasture) 血浆溢上来(I型、III型)